| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 177.983 | 181.510 | - | 175.808 | 160.978 | 190.339 | 152.409 | 130.564 | 82.585 | 7.679 |
| Total Income - EUR | 177.994 | 181.515 | - | 175.808 | 174.132 | 190.339 | 154.779 | 155.007 | 83.595 | 7.700 |
| Total Expenses - EUR | 185.607 | 184.047 | - | 173.449 | 169.620 | 190.420 | 160.051 | 151.065 | 99.927 | 60.290 |
| Gross Profit/Loss - EUR | -7.613 | -2.532 | - | 2.359 | 4.512 | -81 | -5.271 | 3.942 | -16.332 | -52.591 |
| Net Profit/Loss - EUR | -7.188 | -2.532 | - | 601 | 2.768 | -1.892 | -6.819 | 2.425 | -17.170 | -52.663 |
| Employees | 2 | 3 | - | 3 | 3 | 3 | 3 | 2 | 0 | 1 |
Check the financial reports for the company - Antiseptica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 44.629 | 41.042 | - | 38.795 | 38.044 | 37.323 | 36.495 | 36.605 | 36.491 | 36.174 |
| Current Assets | 87.381 | 80.862 | - | 108.874 | 104.121 | 141.638 | 148.498 | 143.621 | 132.744 | -7.156 |
| Inventories | 46.618 | 46.720 | - | 47.826 | 53.438 | 62.759 | 57.476 | 51.892 | 58.000 | 0 |
| Receivables | 31.765 | 25.703 | - | 47.725 | 42.122 | 30.479 | 32.247 | 34.034 | 35.611 | 239 |
| Cash | 8.998 | 8.439 | - | 13.323 | 8.561 | 48.399 | 58.774 | 57.694 | 39.133 | -7.395 |
| Shareholders Funds | 14.067 | 11.392 | - | 14.446 | 16.934 | 14.721 | 7.575 | 10.024 | -7.177 | -59.800 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 117.943 | 110.584 | - | 134.803 | 125.442 | 164.574 | 177.792 | 170.561 | 176.741 | 88.817 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Antiseptica Srl